Latest News and Press Releases

The Kimberly-Clark (NASDAQ:KMB) warehouse blaze caused roughly $500M in damages and highlights multiple larger issues

The race to develop more effective treatments for some of the deadliest forms of cancer is quietly unfolding across biotechnology

Yet one of oncology's greatest challenges, Glioblastoma, remains largely unsolved.

Eli Lilly's (NYSE:LLY) strong Phase 3 results for Retevmo places the oncology community in the spotlight

Biotechnology has always been a sector driven by inflection points, and few milestones matter more than Phase 2 clinical data. $NTHI, $ORKA, $ABVX, $SYRE

Phase 2 and Phase 3 trials are reshaping expectations across obesity, oncology, gene editing, autoimmune disease, and neurological disorders.

Biotechs continue attracting speculative capital as investors aggressively position around next-generation oncology, metabolic disease, and CNS therapy pla

The biologics sector is rapidly emerging as one of the most closely watched growth stories in healthcare $HCWB, $TGNT, $MRNA, $REGN

The U.S. housing and construction sector may be entering its next major consolidation cycle

Advanced materials science sits at the intersection of biology, chemistry, and engineering. $KBLB, $LHX, $HXL, $AVNT, $ASPN